In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
Abstract Background SARS-CoV-2 is a severe respiratory infection that infects humans. Its outburst entitled it as a pandemic emergence. To get a grip on this outbreak, specific preventive and therapeutic interventions are urgently needed. It must be said that, until now, there are no existing vaccin...
Main Authors: | Giulia Russo, Marzio Pennisi, Epifanio Fichera, Santo Motta, Giuseppina Raciti, Marco Viceconti, Francesco Pappalardo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12859-020-03872-0 |
Similar Items
-
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB
by: Giulia Russo, et al.
Published: (2020-12-01) -
Generation of digital patients for the simulation of tuberculosis with UISS-TB
by: Miguel A. Juárez, et al.
Published: (2020-12-01) -
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)
by: Marzio Pennisi, et al.
Published: (2019-12-01) -
In-silico 3D structure analysis accelerates the solution of a real viral structure and antibodies docking mechanism
by: Motohiro eMiki, et al.
Published: (2012-11-01) -
Potentiating Antigen-Specific Antibody Production with Peptides Obtained from In Silico Screening for High-Affinity against MHC-II
by: Yoshiro Hanyu, et al.
Published: (2019-08-01)